Articles from Robbins LLP

SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · March 3, 2025

SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities that purchased or otherwise acquired Quantum Computing Inc. (NASDAQQUBT) securities between March 30, 2020 and January 15, 2025. Quantum Computing (QCI) purportedly uses nonlinear quantum optics to deliver quantum products for high-performance computing applications.
By Robbins LLP · Via GlobeNewswire · March 3, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Block, Inc. (NYSEXYZ) Class A common stock between February 26, 2020 and April 30, 2024. Block is a financial technology conglomerate.
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all shareholders that purchased Venture Global, Inc. (NYSEVG) stock pursuant to the Company's registration statement in support of its initial public offering ("IPO") on January 24, 2025. Venture Global sells liquified natural gas ("LGN").
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSEIIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust (“REIT”) purportedly focused on the acquisition, ownership, and management of specialized properties leased to state-licensed operators for their regulated medical-use cannabis facilities.
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Manhattan Associates, Inc. (NASDAQMANH) securities between October 22, 2024 and January 28, 2025. Manhattan Associates is a global company that develops, sells, deploys, services, and maintains software solutions for the purpose of assisting in the management of supply chains, inventory, and omnichannel operations for its customers.
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired FTAI Aviation Ltd. (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025. FTAI owns and acquires aviation and offshore energy equipment.
By Robbins LLP · Via GlobeNewswire · February 27, 2025

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 25, 2025

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQTMDX) securities between February 28, 2023 and January 10, 2025. TransMedics describes itself as a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.
By Robbins LLP · Via GlobeNewswire · February 25, 2025

SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities that purchased The Trade Desk, Inc. (NASDAQTTD) Class A common stock between May 9, 2024 and February 12, 2025. Trade Desk operates globally as a technology company, offering a self-service, cloud-based, ad-buying platform that allows marketers to plan, manage, optimize, and measure data-driven ad campaigns.
By Robbins LLP · Via GlobeNewswire · February 24, 2025

SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons or entities that purchased or otherwise acquired Semtech Corporation (NASDAQSMTC) securities between August 27, 2024 and February 27, 2025. Semtech is a semiconductor, digital systems, and cloud connectivity service provider.
By Robbins LLP · Via GlobeNewswire · February 24, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Elastic N.V. (NYSEESTC) securities between May 31, 2024 and August 29, 2024. Elastic describes itself as “the Search AI [artificial intelligence] Company[.]”
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Neumora Therapeutics, Inc. (NASDAQNMRA) common stock pursuant to the Offering Documents issued in connection with the Company's initial public offering ("IPO") on September 15, 2023. Neumora is a clinical-stage biopharmaceutical company.
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intellia Therapeutics, Inc. (NASDAQNTLA) securities between June 30, 2024 and January 28, 2025. Intellia describes itself as a leading clinical-stage gene editing company, focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of ICON PLC (NASDAQICLR) ordinary shares between July 27, 2023 and October 23, 2024. ICON is a clinical research organization (CRO).
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all shareholders that purchased Venture Global, Inc. (NYSEVG) stock pursuant to the Company's registration statement in support of its initial public offering ("IPO") on January 24, 2025. Venture Global sells liquified natural gas ("LGN").
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Constellation Brands, Inc. (NYSESTZ) securities between April 11, 2024 and January 8, 2025. Constellation, together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy.
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Monolithic Power Systems Inc. (NASDAQMPWR) common stock between February 8, 2024 and November 8, 2024. Monolithic is a provider of power management components used in electronic systems.
By Robbins LLP · Via GlobeNewswire · February 20, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQTMDX) securities between February 28, 2023 and January 10, 2025. TransMedics describes itself as a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (NASDAQMU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FMC Corporation (NYSEFMC) securities between November 16, 2023 and February 4, 2025. FMC is an agricultural sciences company that develops, markets, and sells crop protection chemicals.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Merck & Co., Inc. (NYSEMRK) securities between February 3, 2022 and February 3, 2025. Merck is a global healthcare company.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQREGN) securities between November 2, 2023 and October 30, 2024. Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
By Robbins LLP · Via GlobeNewswire · February 18, 2025

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Novo Nordisk A/S (NYSENVO) securities between November 2, 2022 and December 19, 2024. Novo is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.
By Robbins LLP · Via GlobeNewswire · February 14, 2025

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. (NASDAQEPIX) securities between December 12, 2023 and October 31, 2024. ESSA is a clinical stage pharmaceutical company that focuses on the development of small molecule drugs for the treatment of prostate cancer. The Company's lead product candidate was masofaniten, which was in clinical trial in combination with enzalutamide compared with enzalutamide alone in patients with metastatic CRPC.
By Robbins LLP · Via GlobeNewswire · February 14, 2025

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Crocs, Inc. (NASDAQCROX) common stock between November 3, 2022 and October 28, 2024. Crocs is a casual lifestyle footwear brand.
By Robbins LLP · Via GlobeNewswire · February 14, 2025

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intellia Therapeutics, Inc. (NASDAQNTLA) securities between June 30, 2024 and January 28, 2025. Intellia describes itself as a leading clinical-stage gene editing company, focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
By Robbins LLP · Via GlobeNewswire · February 13, 2025

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Neumora Therapeutics, Inc. (NASDAQNMRA) common stock pursuant to the Offering Documents issued in connection with the Company's initial public offering ("IPO") on September 15, 2023. Neumora is a clinical-stage biopharmaceutical company.
By Robbins LLP · Via GlobeNewswire · February 13, 2025

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 13, 2025

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 13, 2025

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons or entities that purchased or otherwise acquired Edison International (NYSEEIX) securities between February 25, 2021 and February 6, 2025. Edison is the parent company of Southern California Edison Company (SCE) and Edison Energy Group, Inc.
By Robbins LLP · Via GlobeNewswire · February 13, 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased shares of Integral Ad Science Holding Corp. (NASDAQIAS) common stock between March 2, 2023 and February 27, 2024. IAS is a global software company specializing in digital advertising.
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Polestar Automotive Holding UK PLC (NASDAQPSNY) securities between November 14, 2022 and January 16, 2025. Polestar purports to be “the Swedish electric performance car brand with a focus on uncompromised design and innovation, and the ambition to accelerate the change towards a sustainable future.”
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Cardlytics, Inc. (NASDAQCDLX) securities between March 14, 2024 and August 7, 2024. Cardlytics operates an advertising platform in the U.S. and the U.K.
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grocery Outlet Holding Corp. (NASDAQGO) securities between November 7, 2023 and May 7, 2024. Grocery Outlet is a value retailer of consumables and fresh products sold via a network of independently operated stores across the U.S.
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who sold shares if Arconic Corporation (NYSEARNC) common stock between April 19, 2022 and May 3, 2023. Arconic was a publicly-traded provider of aluminum sheets, plates, and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial, and packaging end markets. Apollo acquired Arconic and assumed Arconic’s obligations on August 18, 2023.
By Robbins LLP · Via GlobeNewswire · February 11, 2025

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSEGSK) between February 5, 2020 and August 14, 2022. GSK is a global pharmaceutical company that develops, manufactures, and markets vaccines and medicines worldwide.
By Robbins LLP · Via GlobeNewswire · February 6, 2025

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Monolithic Power Systems Inc. (NASDAQMPWR) common stock between February 8, 2024 and November 8, 2024. Monolithic is a provider of power management components used in electronic systems.
By Robbins LLP · Via GlobeNewswire · February 6, 2025

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Newmont Corporation (NYSENEM) securities between February 22, 2024 and October 23, 2024. Newmont is the world’s leading gold mining company and producer of copper, silver, zinc and lead.
By Robbins LLP · Via GlobeNewswire · February 6, 2025

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Target Corporation (NYSETGT) stock between August 26, 2022 and November 19, 2024. Target Corporation operates general merchandise discount stores in the United States.
By Robbins LLP · Via GlobeNewswire · February 6, 2025

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Transocean Ltd. (NYSERIG) securities between October 13, 2023 and September 2, 2024. Transocean, together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide.
By Robbins LLP · Via GlobeNewswire · February 5, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Walgreens Boots Alliance, Inc. (NYSEWBA) common stock between April 2, 2020 and January 16, 2025. Walgreens operates as a healthcare, pharmacy, and retail company in the U.S., the United Kingdom, Germany, and internationally.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ModivCare, Inc. (NASDAQMODV) securities between November 3, 2022 and September 15, 2024. ModivCare provides a suite of integrated supportive care solutions for public and private payors and their members.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Polestar Automotive Holding UK PLC (NASDAQPSNY) securities between November 14, 2022 and January 16, 2025. Polestar purports to be “the Swedish electric performance car brand with a focus on uncompromised design and innovation, and the ambition to accelerate the change towards a sustainable future.”
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Nextracker Inc. (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024. Nextracker provides software that enables solar panels to follow the sun's movement across the sky and related products and services.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired TELUS International (Cda) Inc. (NYSETIXT) securities between February 16, 2023 and August 1, 2024. TELUS International purports to design, build, and deliver digital solutions for customer experience, including artificial intelligence (“AI”) services, cloud solutions, and user experience/user interface design.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who sold shares if Arconic Corporation (NYSEARNC) common stock between April 19, 2022 and May 3, 2023. Arconic was a publicly-traded provider of aluminum sheets, plates, and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial, and packaging end markets. Apollo acquired Arconic and assumed Arconic’s obligations on August 18, 2023.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Cardlytics, Inc. (NASDAQCDLX) securities between March 14, 2024 and August 7, 2024. Cardlytics operates an advertising platform in the U.S. and the U.K.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased shares of Integral Ad Science Holding Corp. (NASDAQIAS) common stock between March 2, 2023 and February 27, 2024. IAS is a global software company specializing in digital advertising.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grocery Outlet Holding Corp. (NASDAQGO) securities between November 7, 2023 and May 7, 2024. Grocery Outlet is a value retailer of consumables and fresh products sold via a network of independently operated stores across the U.S.
By Robbins LLP · Via GlobeNewswire · February 3, 2025

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Block, Inc. (NYSESQ) Class A common stock between February 26, 2020 and April 30, 2024. Block is a financial technology conglomerate.
By Robbins LLP · Via GlobeNewswire · January 31, 2025

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSEIIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust (“REIT”) purportedly focused on the acquisition, ownership, and management of specialized properties leased to state-licensed operators for their regulated medical-use cannabis facilities.
By Robbins LLP · Via GlobeNewswire · January 31, 2025

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira BioSciences, Inc. (NASDAQPCRX) securities between August 2, 2023 and August 8, 2024. Pacira is an American pharmaceutical company committed to developing and providing non-opioid pan management and regenerative health solutions.
By Robbins LLP · Via GlobeNewswire · January 31, 2025

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired FTAI Aviation Ltd. (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025. FTAI owns and acquires aviation and offshore energy equipment.
By Robbins LLP · Via GlobeNewswire · January 31, 2025

SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 28, 2025

SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Novo Nordisk A/S (NYSENVO) securities between November 2, 2022 and December 19, 2024. Novo is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.
By Robbins LLP · Via GlobeNewswire · January 28, 2025

SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. (NASDAQEPIX) securities between December 12, 2023 and October 31, 2024. ESSA is a clinical stage pharmaceutical company that focuses on the development of small molecule drugs for the treatment of prostate cancer. The Company's lead product candidate was masofaniten, which was in clinical trial in combination with enzalutamide compared with enzalutamide alone in patients with metastatic CRPC.
By Robbins LLP · Via GlobeNewswire · January 28, 2025

SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of purchasers of DMC Global Inc. (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024. DMC Global is a diversified industrial company.
By Robbins LLP · Via GlobeNewswire · January 24, 2025

SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired FTAI Aviation Ltd. (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025. FTAI owns and acquires aviation and offshore energy equipment.
By Robbins LLP · Via GlobeNewswire · January 24, 2025

SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQKYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued in connection with the Company's initial public offering ("IPO"). Kyverna is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
By Robbins LLP · Via GlobeNewswire · January 24, 2025

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSEIIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust (“REIT”) purportedly focused on the acquisition, ownership, and management of specialized properties leased to state-licensed operators for their regulated medical-use cannabis facilities.
By Robbins LLP · Via GlobeNewswire · January 22, 2025

By Robbins LLP · Via GlobeNewswire · January 22, 2025

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQAZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as "a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology."
By Robbins LLP · Via GlobeNewswire · January 22, 2025

SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
By Robbins LLP · Via GlobeNewswire · January 17, 2025

SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 17, 2025

SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (NASDAQMU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices.
By Robbins LLP · Via GlobeNewswire · January 17, 2025

SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQREGN) securities between November 2, 2023 and October 30, 2024. Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
By Robbins LLP · Via GlobeNewswire · January 17, 2025